Perinatal antibiotic usage and changes in colonization and resistance rates of group B streptococcus and other pathogens

Obstetrics and Gynecology

Volumn 100, Issue 3, 2002, Pages 525-533

  Spaetgens, Renee ^a   DeBella, Kim ^a   Ma, Doreen ^a   Robertson, Sheila ^a   Mucenski, Melissa ^a   Dele Davies, H ^a,b,c  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c ALBERTA CHILDREN'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEFAZOLIN; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; PENICILLIN G; VANCOMYCIN;

ADOLESCENT; ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; CANADA; COHORT ANALYSIS; CONTROLLED STUDY; DELIVERY; DRUG EXPOSURE; DRUG SENSITIVITY; DRUG USE; ESCHERICHIA COLI; FEMALE; FEVER; GESTATION PERIOD; HUMAN; HUMAN TISSUE; LABOR; LABORATORY TEST; MAJOR CLINICAL STUDY; NONHUMAN; PATHOGENESIS; PENICILLIN RESISTANCE; PERINATAL DRUG EXPOSURE; PERINATAL PERIOD; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; RECIPIENT; RECTUM; STREPTOCOCCUS AGALACTIAE; VAGINA;

ADOLESCENT; ADULT; AMPICILLIN; ANTI-BACTERIAL AGENTS; CEFAZOLIN; COHORT STUDIES; COLONY COUNT, MICROBIAL; DRUG RESISTANCE, MICROBIAL; FEMALE; GESTATIONAL AGE; HUMANS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PENICILLINS; PERINATAL CARE; PREGNANCY; PROBABILITY; SENSITIVITY AND SPECIFICITY; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; VAGINA; VAGINAL SMEARS;

EID: 0036711293     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(02)02068-9     Document Type: Article

References (31)

1. PICNIC, Davies H., LeBlanc J., Bortolussi R., McGeer A. The Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of neonatal group B streptococcal infections in Canada. Pediatr Child Health. 4:1999;257-263.
2. Rossetti R., Maranini B., Soldi P. Vaginal colonization by Streptococcus agalactiae in two neighbouring populations in Tuscany. Adv Experiment Med Biol. 418:1997;249-250.
3. Baker C.J., Edwards M.S. Group B streptococcal infections. Remington J.S., Klein J.O., Infectious diseases of the fetus and newborn infant. 4th ed. 1995;980-1054 WB Saunders, Philadelphia, PA.
4. Hickman M., Rench M., Ferrieri P., Baker C. Changing epidemiology of group B streptococcal colonization. Pediatrics. 104:1999;203-209.
5. Yang Y.H., Zhu Y.Z., Zhang J.H., Shen A.D., Zhang G.R., Iontova I.M., et al. Group B streptococcal infections in neonates and its carriage in women. Adv Experiment Med Biol. 418:1997;251-253.
6. The Alberta Neonatal Group B Streptococcal and Toronto Invasive Bacterial Diseases Networks, Davies H., Adair C., Schuchat A., Low D., Sauve R., et al. Physician prevention practices and incidence of neonatal GBS disease in two Canadian regions. Canadian Med Assoc J. 64:2001;479-485.
7. Factor S.H., Levine O.S., Nassar A., Potter J., Fajardo A., O'Sullivan M.J., et al. Impact of a risk-based prevention policy on neonatal group B streptococcal disease. Am J Obstet Gynecol. 179:1998;1568-1571.
8. Benitz W., Gould J., Druzin M. Risk factors for early-onset group B streptococcal sepsis Estimation of odds ratios by critical literature review. Pediatrics. 103:1999;1-23.
9. Anonymous Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. Pediatrics. 99:1997;489-496.
10. Yancey M.K., Schuchat A., Brown L.K., Ventura V.L., Markenson G.R. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstet Gynecol. 88:1996;811-815.
11. Rouse D.J., Goldenberg R.L., Cliver S.P., Cutter G.R., Mennemeyer S.T., Fargason C. Jr. Strategies for the prevention of early-onset neonatal group B streptococcal sepsis A decision analysis. (review) Obstet Gynecol. 83:1994;483-494.
12. Schrag S., Zywicki S., Farley M., Reingold A., Harrison L., Lefkowitz L., et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med. 342:2000;15-20.
13. Towers C.V., Carr M.H., Padilla G., Asrat T. Potential consequences of widespread antepartal use of ampicillin. Am J Obstet Gynecol. 179:1998;879-883.
14. Pearlman M.D., Pierson C.L., Faix R.G. Frequent resistance of clinical group B streptococci isolates to clindamycin and erythromycin. Obstet Gynecol. 92:1998;258-261.
15. Gibbs R.S., Blanco J.D., St Clair P.J., Castaneda Y.S. Vaginal colonization with resistant aerobic bacteria after antibiotic therapy for endometritis. Am J Obstet Gynecol. 142:1982;130-134.
16. Amstey M.S., Gibbs R.S. Is penicillin G a better choice than ampicillin for prophylaxis of neonatal group B streptococcal infections? (review) Obstet Gynecol. 84:1994;1058-1059.
17. Barron E., Cassell H., Duffy L., Eschenbach D., Greenwood J., Harvey S., et al. Laboratory diagnosis of female genital tract infections. 1993;American Society for Microbiology, Washington, DC.
18. Evangelista A., Beilstein H., Laboratory diagnosis of gonorrhea. 1993;American Society for Microbiology, Washington, DC.
19. Isenberg H., Clinical microbiology procedures handbook. 1992;American Society for Microbiology, Washington, DC.
20. Mercer B.M., Carr T.L., Beazley D.D., Crouse D.T., Sibai B.M. Antibiotic use in pregnancy and drug-resistant infant sepsis. Am J Obstet Gynecol. 181:1999;816-821.
21. Davies H., Adair C., Partlow E., Sauve R., Low D., McGeer A. Two-year survey of Alberta laboratories processing of antenatal group B streptococcal (GBS) screening specimens Implications for GBS screening programs. Diagn Microb Inf Dis. 35:1999;169-176.
22. Hager W.D., Schuchat A., Gibbs R., Sweet R., Mead P., Larsen J.W. Prevention of perinatal group B streptococcal infection Current controversies. Obstet Gynecol. 96:2000;141-145.
23. Schuchat A., Zywicki S.S., Dinsmoor M.J., Mercer B., Romaguera J., O'Sullivan M.J., et al. Risk factors and opportunities for prevention of early-onset neonatal sepsis A multicenter case-control study. Pediatrics. 105:2000;21-26.
24. McDuffie R. Jr, McGregor J.A., Gibbs R.S. Adverse perinatal outcome and resistant Enterobacteriaceae after antibiotic usage for premature rupture of the membranes and group B streptococcus carriage. Obstet Gynecol. 82:1993;487-489.
25. Joseph T.A., Pyati S.P., Jacobs N. Neonatal early-onset Escherichia coli disease. The effect of intrapartum ampicillin. Arch Pediatr Adolesc Med. 152:1998;35-140.
26. Levine E.M., Ghai V., Barton J.J., Strom C.M. Intrapartum antibiotic prophylaxis increases the incidence of gram-negative neonatal sepsis. Infect Dis Obstet Gynecol. 7:1999;210-213.
27. Terrone D., Rinehart B., Einstein M., Britt L., Martin J., Perry K. Neonatal sepsis and death caused by resistant Escherichia coli Possible consequences of extended maternal ampicillin administration. Am J Obstet Gynecol. 180:1999;1345-1348.
28. Baltimore R.S., Huie S.M., Meek J.I., Schuchat A., O'Brien K.L. Early-onset neonatal sepsis in the era of group B streptococcal prevention. Pediatrics. 108:2001;1094-1098.
29. Morales W.J., Dickey S.S., Bornick P., Lim D.V. Change in antibiotic resistance of group B streptococcus Impact on intrapartum management. Am J Obstet Gynecol. 181:1999;310-314.
30. Tyrrell G.J., Senzilet L.D., Spika J.S., Kertesz D.A., Alagaratnam M., Lovgren M., et al. Invasive disease due to group B streptococcal infection in adults Results from a Canadian, population-based, active laboratory surveillance study - 1996. Sentinel Health Unit Surveillance System Site Coordinators. J Infect Dis. 182:2000;168-173.
31. Vermillion S.T., Bland M.L., Soper D.E., Austin M. Antibiotic resistance patterns of group B streptococcus in late-third-trimester rectovaginal cultures. Obstet Gynecol. 95:(4 Suppl. 1):2000;S79-S80.